Pericentrosomal localization of the TIG3 tumor suppressor requires an N-terminal hydrophilic region motif

Journal of Investigative Dermatology

Volumn 134, Issue 5, 2014, Pages 1220-1229

  Scharadin, Tiffany M ^a   Adhikary, Gautam ^a   Shaw, Kristin ^a   Grun, Dan J B ^a   Xu, Wen ^a   Eckert, Richard L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOSE; TAZAROTENE INDUCED GENE 3 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; TAZAROTENE INDUCED GENE 3;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOLOGICAL ACTIVITY; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CENTROSOME; HUMAN; KERATINOCYTE; MITOSIS; NONHUMAN; PREPUCE; PROTEIN DOMAIN; SQUAMOUS CELL CARCINOMA; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CENTROSOME; CYTOPLASM; EPIDERMIS; GENES, TUMOR SUPPRESSOR; GREEN FLUORESCENT PROTEINS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KERATINOCYTES; MITOCHONDRIA; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTORS, RETINOIC ACID; SKIN NEOPLASMS;

EID: 84900838845     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.533     Document Type: Article

References (31)

1. Akiyama H, Hiraki Y, Noda M et al. (1999) Molecular cloning and biological activity of a novel Ha-Ras suppressor gene predominantly expressed in skeletal muscle, heart, brain, and bone marrow by differential display using clonal mouse EC cells, ATDC5. J Biol Chem 274:32192-7
2. Anantharaman V, Aravind L (2003) Evolutionary history, structural features and biochemical diversity of the NlpC/P60 superfamily of enzymes. Genome Biol 4:R11
3. Deucher A, Nagpal S, Chandraratna RA et al. (2000) The carboxy-Terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity. Int J Oncol 17:1195-203
4. DiSepio D, Ghosn C, Eckert RL et al. (1998) Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci USA 95:14811-5
5. Doxsey S, Zimmerman W, Mikule K (2005) Centrosome control of the cell cycle. Trends Cell Biol 15:303-11
6. Duvic M, Helekar B, Schulz C et al. (2000) Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res 6:3249-59
7. Duvic M, Nagpal S, Asano AT et al. (1997) Molecular mechanisms of tazarotene action in psoriasis. J Am Acad Dermatol 37:S18-24
8. Duvic M, Ni X, Talpur R et al. (2003) Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. J Invest Dermatol 121:902-9
9. Eckert RL, Sturniolo MT, Jans R et al. (2009) TIG3: A regulator of type I transglutaminase activity in epidermis. Amino Acids 36:739-46
10. Hajnal A, Klemenz R, Schafer R (1994) Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts. Oncogene 9:479-90
11. Han BG, Cho JW, Cho YD et al. (2010) Expression, purification and biochemical characterization of the N-Terminal regions of human TIG3 and HRASLS3 proteins. Protein Expr Purif 71:103-7
12. Huang SL, Shyu RY, Yeh MY et al. (2000) Cloning and characterization of a novel retinoid-inducible gene 1(RIG1) deriving from human gastric cancer cells. Mol Cell Endocrinol 159:15-24
13. Husmann K, Sers C, Fietze E et al. (1998) Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12. Oncogene 17:1305-12
14. Jahng WJ, Xue L, Rando RR (2003) Lecithin retinol acyltransferase is a founder member of a novel family of enzymes. Biochemistry 42:12805-12
15. Jans R, Sturniolo MT, Eckert RL (2008) Localization of the TIG3 transglutaminase interaction domain and demonstration that the amino-Terminal region is required for TIG3 function as a keratinocyte differentiation regulator. J Invest Dermatol 128:517-29
16. Jiang SY, Wu MS, Chen LM et al. (2005) Identification and characterization of the retinoic acid response elements in the human RIG1 gene promoter. Biochem Biophys Res Commun 331:630-9
17. Lim HH, Zhang T, Surana U (2009) Regulation of centrosome separation in yeast and vertebrates: Common threads. Trends Cell Biol 19:325-33
18. Ou CC, Hsu SC, Hsieh YH et al. (2008) Downregulation of HER2 by RIG1 involves the PI3K/Akt pathway in ovarian cancer cells. Carcinogenesis 29:299-306
19. Ren X, Lin J, Jin C et al. (2010a) 1H, 13C and 15N resonance assignments of human H-REV107 N-Terminal domain. Biomol NMR Assign 4:175-8
20. Ren X, Lin J, Jin C et al. (2010b) Solution structure of the N-Terminal catalytic domain of human H-REV107-A novel circular permutated NlpC/P60 domain. FEBS Lett 584:4222-6
21. Scharadin TM, Jiang H, Jans R et al. (2011) TIG3 tumor suppressor-dependent organelle redistribution and apoptosis in skin cancer cells. PLoS ONE 6:e23230
22. Scharadin TM, Jiang H, Martin S et al. (2012) TIG3 interaction at the centrosome alters microtubule distribution and centrosome function. J Cell Sci 125:2604-14
23. Schliwa M, Woehlke G (2003) Molecular motors. Nature 422:759-65
24. Sers C, Emmenegger U, Husmann K et al. (1997) Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors. J Cell Biol 136:935-44
25. Shyu RY, Chang SC, Yu JC et al. (2005) Expression and regulation of retinoidinducible gene 1 (RIG1) in breast cancer. Anticancer Res 25:2453-60
26. Soldati T, Schliwa M (2006) Powering membrane traffic in endocytosis and recycling. Nat Rev Mol Cell Biol 7:897-908
27. Sturniolo MT, Chandraratna RA, Eckert RL (2005) A novel transglutaminase activator forms a complex with type 1 transglutaminase. Oncogene 24:2963-72
28. Sturniolo MT, Dashti SR, Deucher A et al. (2003) A novel tumor suppressor protein promotes keratinocyte terminal differentiation via activation of type I transglutaminase. J Biol Chem 278:48066-73
29. Tsai FM, Shyu RY, Jiang SY (2007) RIG1 suppresses Ras activation and induces cellular apoptosis at the Golgi apparatus. Cell Signal 19:989-99
30. Uyama T, Jin XH, Tsuboi K et al. (2009a) Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes. Biochim Biophys Acta 1791:1114-24
31. Uyama T, Morishita J, Jin XH et al. (2009b) The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1/2 of the thiol hydrolase type. J Lipid Res 50:685-93